Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) announced a profit for its first quarter that Increased, from the same period last year
The company's earnings totaled RMB48.65 million, or RMB0.0257 per share. This compares with RMB41.24 million, or RMB0.0217 per share, last year.
The company's revenue for the period fell 12.4% to RMB1.263 billion from RMB1.441 billion last year.
Guizhou Xinbang Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB48.65 Mln. vs. RMB41.24 Mln. last year.-EPS: RMB0.0257 vs. RMB0.0217 last year.-Revenue: RMB1.263 Bln vs. RMB1.441 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.